Research progress of sepsis-related biomarkers and mechanisms of action

doi:10.3760/cma.j.issn.1007-1245.2022.10.033

Abstract

Abstract: Sepsis is a common clinical syndrome of multiple organ dysfunction caused by a critical infection, and is one of the major clinical causes of patients' death, with a high morbidity and mortality. Despite significant improvements in antibiotic use and life support, the mortality in patients with sepsis is still high. Early identification of biomarker changes in sepsis is of great benefit in providing ideas for the treatment of sepsis and determining the prognosis of patients.

Key words: Sepsis, Biomarkers, Procalcitonin

摘要： 脓毒症是临床中常见的一种危重症感染导致的多器官功能障碍综合征，也是临床中常见的患者死亡的主要原因之一，具有高发病率、高病死率的特点，尽管现在抗生素利用和生命支持方面有了很大的改善，但是脓毒症患者病死率仍居高不下，早期识别脓毒症生物标志物变化，对脓毒症治疗提供思路、判断患者预后有很大益处。

关键词:

"> 脓毒症, 生物标志物, 降钙素原

Guo Runjing, Hao Dong. Research progress of sepsis-related biomarkers and mechanisms of action[J]. International Medicine and Health Guidance News, 2022, 28(10): 1468-1471.

郭润静, 郝东. 脓毒症相关生物标志物及作用机制研究进展[J]. 国际医药卫生导报, 2022, 28(10): 1468-1471.

References

[1] Iskander KN, Osuchowski MF, Stearns-Kurosawa DJ, et al. Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding[J].Physiol Rev,2013,93(3):1247-1288. DOI:10.1152/physrev.00037.2012.

[2] Faix JD. Biomarkers of sepsis[J].Crit Rev Clin Lab Sci,2013,50(1):23-36. DOI:10.3109/10408363.2013.764490.

[3] Reinhart K, Meisner M, Brunkhorst FM. Markers for sepsis diagnosis: what is useful?[J].Crit Care Clin,2006,22(3):503-519. DOI:10.1016/j.ccc.2006.03.003.

[4] Smok B, Domagalski K, Pawłowska M. Diagnostic and prognostic value of IL-6 and sTREM-1 in SIRS and sepsis in children[J].Mediators Inflamm,2020,2020:8201585. DOI:10.1155/2020/8201585.

[5] Song J, Park DW, Moon S, et al. Diagnostic and prognostic value of interleukin-6, pentraxin 3, and procalcitonin levels among sepsis and septic shock patients: a prospective controlled study according to the Sepsis-3 definitions[J].BMC Infect Dis,2019,19(1):968. DOI:10.1186/s12879-019-4618-7.

[6] 吴智慧,郑洁,黄伟,等. 血清白细胞介素-6对感染相关脓毒症患者病情的评估效果[J]. 中华医院感染学杂志,2019,29(17):2580-2583. DOI:10.11816/cn.ni.2019-183939.

[7] 胡婧,都鹏飞,贝丹丹. 外周血IL-6对新生儿脓毒症诊断价值的meta分析[J]. 中国当代儿科杂志,2015,17(11):1176-1182. DOI:10.7499/j.issn.1008-8830.2015.11.006.

[8] Stryjewski GR, Nylen ES, Bell MJ, et al. Interleukin-6, interleukin-8, and a rapid and sensitive assay for calcitonin precursors for the determination of bacterial sepsis in febrile neutropenic children[J].Pediatr Crit Care Med,2005,6(2):129-135. DOI:10.1097/01.PCC. 0000149317.15274.48.

[9] Bozza FA, Salluh JI, Japiassu AM, et al. Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis[J].Crit Care,2007,11(2):R49. DOI:10.1186/cc5783.

[10] 瞿云,张子洲,史志勇,等. 老年肺部感染并发脓毒症患者MCP-1与HGF和炎症因子的表达水平[J]. 中华医院感染学杂志,2021,31(20):3073-3077. DOI:10.11816/cn.ni.2021- 210008.

[11] Mierzchała-Pasierb M, Lipińska-Gediga M. Sepsis diagnosis and monitoring - procalcitonin as standard, but what next?[J].Anaesthesiol Intensive Ther,2019,51(4):299-305. DOI:10.5114/ait.2019.88104.

[12] Vijayan AL, Vanimaya, Ravindran S, et al. Procalcitonin: a promising diagnostic marker for sepsis and antibiotic therapy[J].J Intensive Care,2017,5:51. DOI:10.1186/s40560-017-0246-8.

[13] 周晓芬,于荣国,张颖蕊,等. 内皮细胞特异性分子-1、血清降钙素原、免疫炎性因子C反应蛋白、白细胞介素-6在脓毒症中的诊断价值[J]. 中华实验外科杂志,2018,35(7):1315-1317. DOI:10.3760/cma.j.issn.1001-9030. 2018. 07.040.

[14] 王皓,辛娜,许雪侠,等.临床指标与ICU老年肺部感染患者预后的关系[J/CD].中华重症医学电子杂志(网络版),2021,7(1):14-20.

[15] Benzaquen LR, Yu H, Rifai N. High sensitivity C-reactive protein: an emerging role in cardiovascular risk assessment[J].Crit Rev Clin Lab Sci,2002,39(4-5):459-497. DOI:10.1080/10408360290795556.

[16] Allin KH, Nordestgaard BG. Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer[J].Crit Rev Clin Lab Sci,2011,48(4):155-170. DOI:10.3109/10408363.2011.599831.

[17] Hofer N, Zacharias E, Müller W, et al. An update on the use of C-reactive protein in early-onset neonatal sepsis: current insights and new tasks[J].Neonatology,2012,102(1):25-36. DOI:10.1159/000336629.

[18] 梅婉雯,姚峰,浦秦华,等. 炎症因子和Lac在脓毒症病情及预后中的评估价值[J]. 中华医院感染学杂志,2021,31(20):3051-3055. DOI:10.11816/cn.ni.2021-210077.

[19] 陆洋,沈浩亮,崔晓莉,等. C-反应蛋白和NT-pro BNP对老年脓毒症患者死亡和多器官衰竭的预测价值[J]. 中国老年学杂志,2021,41(18):4011-4014. DOI:10.3969/j.issn.1005- 9202.2021.18.038.

[20] Davis BH, Olsen SH, Ahmad E, et al. Neutrophil CD64 is an improved indicator of infection or sepsis in emergency department patients[J].Arch Pathol Lab Med,2006,130(5):654-661. DOI:10.5858/2006-130-654-NCIAII.

[21] Zola H, Swart B, Banham A, et al. CD molecules 2006--human cell differentiation molecules[J].J Immunol Methods,2007,319(1-2):1-5. DOI:10.1016/j.jim. 2006.11.001.

[22] Song SH, Kim HK, Park MH, et al. Neutrophil CD64 expression is associated with severity and prognosis of disseminated intravascular coagulation[J].Thromb Res,2008,121(4):499-507. DOI:10.1016/j.thromres. 2007. 05.013.

[23] Patnaik R, Azim A, Agarwal V. Neutrophil CD64 a diagnostic and prognostic marker of sepsis in adult critically ill patients: a brief review[J].Indian J Crit Care Med,2020,24(12):1242-1250. DOI:10.5005/jp-journals-10071-23558.

[24] Danikas DD, Karakantza M, Theodorou GL, et al. Prognostic value of phagocytic activity of neutrophils and monocytes in sepsis. Correlation to CD64 and CD14 antigen expression[J].Clin Exp Immunol,2008,154(1):87-97. DOI:10.1111/j.1365-2249.2008.03737.x.

[25] 邹晖,叶正龙,刘尚香,等. 中性粒细胞CD64指数对ICU脓毒症患者的诊断价值[J]. 中华危重病急救医学,2021,33(6):676-679. DOI:10.3760/cma.j.cn121430-20210119- 00080.

[26] Bouchon A, Dietrich J, Colonna M. Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes[J].J Immunol,2000,164(10):4991-4995. DOI:10.4049/jimmunol.164.10.4991.

[27] Bouchon A, Facchetti F, Weigand MA, et al. TREM-1 amplifies inflammation and is a crucial mediator of septic shock[J].Nature,2001,410(6832):1103-1107. DOI:10.1038/35074114.

[28] Arts RJ, Joosten LA, van der Meer JW, et al. TREM-1: intracellular signaling pathways and interaction with pattern recognition receptors[J].J Leukoc Biol,2013,93(2):209-215. DOI:10.1189/jlb.0312145.

[29] Wu J, Li J, Salcedo R, et al. The proinflammatory myeloid cell receptor TREM-1 controls Kupffer cell activation and development of hepatocellular carcinoma[J].Cancer Res,2012,72(16):3977-3986. DOI:10.1158/0008-5472.CAN-12-0938.

[30] Fu L, Han L, Xie C, et al. Identification of extracellular actin as a ligand for triggering receptor expressed on myeloid cells-1 signaling[J].Front Immunol,2017,8:917. DOI:10.3389/fimmu.2017.00917.

[31] Read CB, Kuijper JL, Hjorth SA, et al. Cutting Edge: identification of neutrophil PGLYRP1 as a ligand for TREM-1[J].J Immunol,2015,194(4):1417-1421. DOI:10.4049/jimmunol.1402303.

[32] Maiese A, Bolino G, Mastracchio A, et al. An immunohistochemical study of the diagnostic value of TREM-1 as marker for fatal sepsis cases[J].Biotech Histochem,2019,94(3):159-166. DOI:10.1080/10520295. 2018.1535138.

[33] 张洪齐,赵华英,杨超,等. 血浆可溶性髓样细胞触发受体1对成人脓毒症患者诊断价值的meta分析[J/CD]. 中华危重症医学杂志(电子版),2019,12(5):328-334. DOI:10.3877/cma.j.issn.1674-6880.2019.05.008.

[34] Chertov O, Michiel DF, Xu L, et al. Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8- stimulated neutrophils[J].J Biol Chem,1996,271(6):2935-2940. DOI:10.1074/jbc.271.6.2935.

[35] Gautam N, Olofsson AM, Herwald H, et al. Heparin-binding protein (HBP/CAP37): a missing link in neutrophil-evoked alteration of vascular permeability[J].Nat Med,2001,7(10):1123-1127. DOI:10.1038/nm1001-1123.

[36] Bentzer P, Fisher J, Kong HJ, et al. Heparin-binding protein is important for vascular leak in sepsis[J].Intensive Care Med Exp,2016,4(1):33. DOI:10.1186/s40635-016-0104-3.

[37] 刘艺,马林沁,吴彩军. 肝素结合蛋白联合SOFA评分对老年脓毒症患者预后的早期预测价值[J]. 中华急诊医学杂志,2020,29(12):1613-1617. DOI:10.3760/cma.j.issn.1671-0282.2020.12.020.

[38] Fiedler U, Augustin HG. Angiopoietins: a link between angiogenesis and inflammation[J].Trends Immunol,2006,27(12):552-558. DOI:10.1016/j.it.2006.10.004.

[39] Melendez E, Whitney JE, Norton JS, et al. Systemic angiopoietin-1/2 dysregulation in pediatric sepsis and septic shock[J].Int J Med Sci,2019,16(2):318-323. DOI:10.7150/ijms.27731.

[40] 王凯旋,徐丽丹,姜雪燕,等. 血管生成素2与炎症因子在脓毒症患儿中的表达[J/CD]. 中华妇幼临床医学杂志(电子版),2019,15(3):328-333. DOI:10.3877/cma.j.issn.1673- 5250.2019.03.014.

[41] 李育梅,陈聪德,张丹如,等. 重症脓毒症患儿血乳酸、肌钙蛋白、凝血指标动态变化特点及与预后的关系分析[J]. 中华医院感染学杂志,2020,30(23):3544-3547. DOI:10.11816/cn.ni.2020-192597.

[42] 王义,张华,唐小晶,等. 脓毒症患儿预后相关危险因素的回顾性研究[J]. 中华危重病急救医学,2020,32(6):707-710. DOI:10.3760/cma.j.cn121430-20200225-00094.

[43] 伊孙邦,胡雨峰,林素涵,等. 不同时间段血乳酸水平对脓毒症院内死亡的预测价值比较:基于重症监护医学信息数据库[J/CD]. 中华危重症医学杂志(电子版),2020,13(1):39-43. DOI:10.3877/cma.j.issn.1674-6880.2020.01.008.